Vault-13

Blue Owl Capital Holdings LP

New York, NY · CIK 1858703 · 13F filing filed 2026-08-11

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$658.0m reported value +80.8% vs Q1 2026
71positions
79.3%in top 10
18 new 11 added 13 reduced 15 sold out vs Q1 2026

Options: 5 call positions ($6.5m notional), 0 put positions (— notional) – listed below, not included above.

This report includes the holdings of 10 other managers that share the investment decisions:

2 more
  • Blue Owl Insurance Advisors LLC – no 13F of its own this quarter
  • Blue Owl Technology Credit Advisors LLC – no 13F of its own this quarter

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SPACE EXPLORATION TECHN CORP CLASS A COM STK SPCX SPCX 1,398,815 $239.0m36.32% 36.32% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.4m
2 AKTIS ONCOLOGY INC COM AKTS AKTS 3,070,219 $99.0m15.04% 15.04% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 3.2m, Q2 2026 3.1m -91.1k -91,129 -2.9%
3 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,539,764 $28.0m4.26% 4.26% ReducedShares held: Q3 2025 2.5m, Q4 2025 2.4m, Q1 2026 1.9m, Q2 2026 1.5m -370.0k -370,000 -19.4%
4 LARIMAR THERAPEUTICS INC COM LRMR LRMR 9,163,157 $27.9m4.25% 4.25% AddedShares held: Q3 2025 5.9m, Q4 2025 6.8m, Q1 2026 7.1m, Q2 2026 9.2m +2.0m +2,043,150 28.7%
5 NUVEEN CHURCHILL DIRECT LEND COM SHS NCDL NCDL 2,143,626 $26.6m4.05% 4.05% UnchangedShares held: Q3 2025 3.1m, Q4 2025 2.1m, Q1 2026 2.1m, Q2 2026 2.1m
6 MAPLIGHT THERAPEUTICS INC COM MPLT MPLT 729,929 $26.2m3.98% 3.98% ReducedShares held: Q3 2025 0, Q4 2025 327.1k, Q1 2026 1.0m, Q2 2026 729.9k -276.0k -276,000 -27.4%
7 CAPITAL ONE FINL CORP COM COF COF 119,757 $24.0m3.65% 3.65% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 119.8k
8 BLUE OWL CAPITAL CORPORATION COM OBDC OBDC 2,045,070 $22.2m3.38% 3.38% UnchangedShares held: Q3 2025 2.0m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.0m
9 DEEP FISSION INC COM FISN FISN 1,333,333 $14.7m2.24% 2.24% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.3m
10 DELL TECHNOLOGIES INC CL C DELL DELL 32,961 $14.2m2.16% 2.16% AddedShares held: Q3 2025 52.3k, Q4 2025 53.8k, Q1 2026 13.9k, Q2 2026 33.0k +19.1k +19,062 137.2%
11 HOLLEY INC COM HLLY HLLY 4,376,888 $11.2m1.70% 1.70% AddedShares held: Q3 2025 4.9m, Q4 2025 4.1m, Q1 2026 4.2m, Q2 2026 4.4m +140.0k +140,000 3.3%
12 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 762,594 $10.9m1.66% 1.66% ReducedShares held: Q3 2025 367.6k, Q4 2025 392.6k, Q1 2026 912.6k, Q2 2026 762.6k -150.0k -150,000 -16.4%
13 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 1,260,544 $9.7m1.48% 1.48% AddedShares held: Q3 2025 1.3m, Q4 2025 1.2m, Q1 2026 333.9k, Q2 2026 1.3m +926.7k +926,667 277.6%
14 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 608,600 $9.1m1.38% 1.38% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 545.0k, Q2 2026 608.6k +63.6k +63,600 11.7%
15 ARTIVA BIOTHERAPEUTICS INC COM ARTV ARTV 874,542 $8.5m1.29% 1.29% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 874.5k
16 COMPASS THERAPEUTICS INC COM CMPX CMPX 3,624,076 $7.9m1.21% 1.21% AddedShares held: Q3 2025 2.6m, Q4 2025 3.5m, Q1 2026 2.9m, Q2 2026 3.6m +682.6k +682,551 23.2%
17 CONDUENT INC COM CNDT CNDT 5,036,595 $7.4m1.12% 1.12% UnchangedShares held: Q3 2025 4.5m, Q4 2025 4.8m, Q1 2026 5.0m, Q2 2026 5.0m
18 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 61,455 $6.8m1.04% 1.04% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 61.5k, Q2 2026 61.5k
19 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 450,000 $6.4m0.97% 0.97% NewShares held: Q3 2025 604.9k, Q4 2025 469.9k, Q1 2026 0, Q2 2026 450.0k
20 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 182,638 $6.1m0.93% 0.93% ReducedShares held: Q3 2025 422.4k, Q4 2025 212.6k, Q1 2026 302.6k, Q2 2026 182.6k -120.0k -120,000 -39.6%
21 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 36,259 $5.5m0.84% 0.84% AddedShares held: Q3 2025 95.3k, Q4 2025 40.3k, Q1 2026 31.3k, Q2 2026 36.3k +5.0k +5,000 16.0%
22 IMAGENEBIO INC COM IMA IMA 917,692 $5.4m0.82% 0.82% ReducedShares held: Q3 2025 540.9k, Q4 2025 823.8k, Q1 2026 959.3k, Q2 2026 917.7k -41.6k -41,645 -4.3%
23 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 260,000 $4.8m0.73% 0.73% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 260.0k
24 IMMIX BIOPHARMA INC COM IMMX IMMX 437,552 $4.5m0.69% 0.69% ReducedShares held: Q3 2025 0, Q4 2025 986.2k, Q1 2026 547.6k, Q2 2026 437.6k -110.0k -110,000 -20.1%
25 ORIC PHARMACEUTICALS INC COM ORIC ORIC 400,000 $4.3m0.66% 0.66% AddedShares held: Q3 2025 0, Q4 2025 515.0k, Q1 2026 150.0k, Q2 2026 400.0k +250.0k +250,000 166.7%
26 LENZ THERAPEUTICS INC COM LENZ LENZ 756,722 $4.3m0.65% 0.65% AddedShares held: Q3 2025 0, Q4 2025 150.0k, Q1 2026 506.7k, Q2 2026 756.7k +250.0k +250,000 49.3%
27 AQUESTIVE THERAPEUTICS INC COM AQST AQST 942,932 $3.9m0.60% 0.60% ReducedShares held: Q3 2025 1.2m, Q4 2025 525.0k, Q1 2026 1.3m, Q2 2026 942.9k -405.0k -405,000 -30.1%
28 STARWOOD PPTY TR INC COM STWD STWD 196,355 $3.2m0.49% 0.49% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 158.5k, Q2 2026 196.4k +37.8k +37,810 23.9%
29 EVOMMUNE INC COM SHS EVMN EVMN 180,000 $2.4m0.36% 0.36% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 100.0k, Q2 2026 180.0k +80.0k +80,000 80.0%
30 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 566,509 $2.2m0.34% 0.34% ReducedShares held: Q3 2025 979.9k, Q4 2025 1.9m, Q1 2026 1.4m, Q2 2026 566.5k -853.4k -853,403 -60.1%
31 CABALETTA BIO INC COM CABA CABA 714,710 $2.2m0.34% 0.34% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 714.7k
32 CHIME FINL INC COM SHS CL A CHYM CHYM 89,878 $1.8m0.28% 0.28% NewShares held: Q3 2025 0, Q4 2025 39.9k, Q1 2026 0, Q2 2026 89.9k
33 CONTEXT THERAPEUTICS INC COM CNTX CNTX 2,934,015 $1.6m0.25% 0.25% ReducedShares held: Q3 2025 7.4m, Q4 2025 7.4m, Q1 2026 5.1m, Q2 2026 2.9m -2.2m -2,155,000 -42.4%
34 WW INTL INC COM NEW WW WW 84,399 $1.3m0.20% 0.20% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 95.6k, Q2 2026 84.4k -11.2k -11,235 -11.8%
35 MARKER THERAPEUTICS INC COM NEW MRKR MRKR 554,250 $814.7k0.12% 0.12% UnchangedShares held: Q3 2025 554.2k, Q4 2025 554.2k, Q1 2026 554.2k, Q2 2026 554.2k
36 ADC THERAPEUTICS SA SHS ADCT ADCT 733,568 $784.9k0.12% 0.12% UnchangedShares held: Q3 2025 733.6k, Q4 2025 733.6k, Q1 2026 733.6k, Q2 2026 733.6k
37 CYBIN INC COM NEW COM NEW 59,911 $396.0k0.06% 0.06% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 59.9k
38 FTAC EMERALD ACQUISITION COR CLASS A COM FLD FLD 856,632 $385.5k0.06% 0.06% UnchangedShares held: Q3 2025 856.6k, Q4 2025 856.6k, Q1 2026 856.6k, Q2 2026 856.6k
39 NIOCORP DEVS LTD *W EXP 03/17/202 NIOBW NIOBW 268,280 $381.0k0.06% 0.06% ReducedShares held: Q3 2025 546.4k, Q4 2025 876.1k, Q1 2026 320.1k, Q2 2026 268.3k -51.8k -51,820 -16.2%
40 REZOLVE AI PLC *W EXP 08/15/202 RZLVW RZLVW 235,121 $214.0k0.03% 0.03% UnchangedShares held: Q3 2025 292.9k, Q4 2025 289.3k, Q1 2026 235.1k, Q2 2026 235.1k
41 BRAND ENGAGEMENT NETWORK INC *W EXP 03/14/202 BNAIW BNAIW 1,453,808 $203.5k0.03% 0.03% ReducedShares held: Q3 2025 1.7m, Q4 2025 2.7m, Q1 2026 1.7m, Q2 2026 1.5m -213.0k -213,000 -12.8%
42 PIPER SANDLER COMPANIES COM NEW PIPR PIPR 2,428 $175.6k0.03% 0.03% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.4k, Q2 2026 2.4k
43 ENGENE THERAPEUTICS INC *W EXP 10/31/202 ENGNW ENGNW 511,177 $148.2k0.02% 0.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 511.2k
44 CELCUITY INC COM CELC CELC 1,249 $130.7k0.02% 0.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2k
45 STABLECOINX INC *W EXP 06/25/203 USDEW USDEW 250,000 $102.5k0.02% 0.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
46 ENERGY TRANSFER L P COM UT LTD PTN ET ET 5,326 $101.8k0.02% 0.02% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.3k, Q2 2026 5.3k
47 CARIS LIFE SCIENCES INC COM CAI CAI 4,711 $84.0k0.01% 0.01% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.7k, Q2 2026 4.7k
48 VODAFONE GROUP PLC NEW SPONSORED ADR VOD VOD 5,371 $71.0k0.01% 0.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.4k
49 DAVE INC *W EXP 01/05/202 DAVEW DAVEW 28,750 $68.4k0.01% 0.01% UnchangedShares held: Q3 2025 28.8k, Q4 2025 28.8k, Q1 2026 28.8k, Q2 2026 28.8k
50 MURANO GLOBAL INVTS PLC SHS MRNO MRNO 261,875 $62.9k0.01% 0.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 261.9k
51 ALPHA MODUS HLDGS INC *W EXP 12/13/202 AMODW AMODW 1,854,665 $55.6k0.01% 0.01% UnchangedShares held: Q3 2025 1.9m, Q4 2025 1.9m, Q1 2026 1.9m, Q2 2026 1.9m
52 ROADZEN INC *W EXP 11/30/202 RDZNW RDZNW 225,000 $42.8k0.01% 0.01% UnchangedShares held: Q3 2025 225.0k, Q4 2025 225.0k, Q1 2026 225.0k, Q2 2026 225.0k
53 ALPHA MODUS HLDGS INC CL A NEW AMOD AMOD 9,853 $42.0k0.01% 0.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.9k
54 AEON BIOPHARMA INC CL A NEW AEON AEON 42,353 $30.5k0.00% 0.00% UnchangedShares held: Q3 2025 42.4k, Q4 2025 43.4k, Q1 2026 42.4k, Q2 2026 42.4k
55 SOUTHLAND HLDGS INC *W EXP 02/14/202 SLND.WS SLND.WS 860,302 $25.8k0.00% 0.00% UnchangedShares held: Q3 2025 860.3k, Q4 2025 860.3k, Q1 2026 860.3k, Q2 2026 860.3k
56 BLUE GOLD LTD *W EXP 04/01/203 BGLWW BGLWW 175,000 $21.0k0.00% 0.00% UnchangedShares held: Q3 2025 175.0k, Q4 2025 175.0k, Q1 2026 175.0k, Q2 2026 175.0k
57 SHF HOLDINGS INC CL A NEW CL A NEW 75,897 $18.2k0.00% 0.00% UnchangedShares held: Q3 2025 75.9k, Q4 2025 75.9k, Q1 2026 75.9k, Q2 2026 75.9k
58 BLACKSKY TECHNOLOGY INC *W EXP 09/09/202 *W EXP 09/09/202 350,000 $17.5k0.00% 0.00% UnchangedShares held: Q3 2025 350.0k, Q4 2025 350.0k, Q1 2026 350.0k, Q2 2026 350.0k
59 TEVOGEN BIO HLDGS INC *W EXP 02/14/202 TVGNW TVGNW 200,000 $12.0k0.00% 0.00% UnchangedShares held: Q3 2025 200.0k, Q4 2025 200.0k, Q1 2026 200.0k, Q2 2026 200.0k
60 ZEO ENERGY CORP *W EXP 03/13/202 ZEOWW ZEOWW 250,000 $10.0k0.00% 0.00% NewShares held: Q3 2025 250.0k, Q4 2025 250.0k, Q1 2026 0, Q2 2026 250.0k
61 LIVEWIRE GROUP INC *W EXP 09/26/202 LVWR.WS LVWR.WS 400,000 $8.0k0.00% 0.00% NewShares held: Q3 2025 400.0k, Q4 2025 500.0k, Q1 2026 0, Q2 2026 400.0k
62 NVNI GROUP LIMITED *W EXP 11/01/202 NVNWF NVNWF 200,000 $6.0k0.00% 0.00% NewShares held: Q3 2025 200.0k, Q4 2025 200.0k, Q1 2026 0, Q2 2026 200.0k
63 KATAPULT HOLDINGS INC COM NEW KPLT KPLT 5,421 $5.4k0.00% 0.00% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.4k, Q2 2026 5.4k
64 CID HOLDCO INC *W EXP 12/31/202 DAICW DAICW 444,515 $4.4k0.00% 0.00% UnchangedShares held: Q3 2025 300.0k, Q4 2025 300.0k, Q1 2026 444.5k, Q2 2026 444.5k
65 BAIRD MED INVT HLDGS LTD *W EXP 10/01/202 BDMDW BDMDW 100,000 $4.0k0.00% 0.00% UnchangedShares held: Q3 2025 100.0k, Q4 2025 100.0k, Q1 2026 100.0k, Q2 2026 100.0k
66 PAGAYA TECHNOLOGIES LTD *W EXP 09/01/202 PGYWW PGYWW 48,661 $2.4k0.00% 0.00% UnchangedShares held: Q3 2025 48.7k, Q4 2025 48.7k, Q1 2026 48.7k, Q2 2026 48.7k
67 STARDUST PWR INC *W EXP 06/21/202 SDSTW SDSTW 16,666 $2.2k0.00% 0.00% UnchangedShares held: Q3 2025 16.7k, Q4 2025 31.7k, Q1 2026 16.7k, Q2 2026 16.7k
68 LIMINATUS PHARMA INC. *W EXP 04/30/203 LIMNW LIMNW 50,000 $2.0k0.00% 0.00% UnchangedShares held: Q3 2025 50.0k, Q4 2025 50.0k, Q1 2026 50.0k, Q2 2026 50.0k
69 WALDENCAST PLC *W EXP 07/27/202 MLKWF MLKWF 33,333 $1.7k0.00% 0.00% UnchangedShares held: Q3 2025 33.3k, Q4 2025 33.3k, Q1 2026 33.3k, Q2 2026 33.3k
70 XBP EUROPE HOLDINGS INC *W EXP 11/30/202 XBPEW XBPEW 24,778 $1.5k0.00% 0.00% UnchangedShares held: Q3 2025 24.8k, Q4 2025 24.8k, Q1 2026 24.8k, Q2 2026 24.8k
71 ASPIRE BIOPHARMA HLDGS INC *W EXP 02/14/203 ASBPW ASBPW 50,000 $1.0k0.00% 0.00% UnchangedShares held: Q3 2025 50.0k, Q4 2025 50.0k, Q1 2026 50.0k, Q2 2026 50.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ENGENE HOLDINGS INC 4,416,353 $30.1m4.4m shares
CIVEO CORP CDA CVEO CVEO 180,475 $4.8m180.5k shares
KALVISTA PHARMACEUTICALS INC KALV KALV 215,000 $4.3m215.0k shares
OVID THERAPEUTICS INC OVID OVID 1,904,666 $4.2m1.9m shares
PLIANT THERAPEUTICS INC PLRX PLRX 2,969,199 $3.7m3.0m shares
ENGENE HOLDINGS INC 511,177 $1.3m511.2k shares
ENTERPRISE PRODS PARTNERS L EPD EPD 31,290 $1.2m31.3k shares
SYNTEC OPTICS HLDGS INC OPTXW OPTXW 803,132 $867.4k803.1k shares
CARDINAL HEALTH INC CAH CAH 1,718 $363.0k1.7k shares
ALPHA MODUS HLDGS INC 394,078 $145.8k394.1k shares
CID HOLDCO INC 557,361 $94.8k557.4k shares
VODAFONE GROUP PLC 5,371 $80.7k5.4k shares
GOHEALTH INC 40,770 $61.6k40.8k shares
BITCOIN DEPOT INC 50,000 $1.0k50.0k shares
KATAPULT HOLDINGS INC 400,000 $0400.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
COMPASS PATHWAYS PLC CMPS · Call CMPSCall 1,670,500 $5.2m1.7m shares Reduced
ERASCA INC ERAS · Call ERASCall 100,000 $795.0k100.0k shares New
ELEDON PHARMACEUTICALS INC ELDN · Call ELDNCall 200,000 $285.0k200.0k shares New
LARIMAR THERAPEUTICS INC LRMR · Call LRMRCall 728,600 $145.7k728.6k shares Reduced
COMPASS THERAPEUTICS INC CMPX · Call CMPXCall 303,800 $106.3k303.8k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
LARIMAR THERAPEUTICS INC LRMR · 13G · filed 2026-05-14 LRMR 10.0%≈ $32.8m no change 13G 2026-05-14
MARKER THERAPEUTICS INC MRKR · 13G · filed 2025-05-15 MRKR 10.0%≈ $1.7m +4.8 pts 13G 2025-05-15
FINANCE OF AMERICA COMPAN FOA · 13G · filed 2026-02-12 FOA 9.5%≈ $22.8m new 13G 2026-02-12
IMAGENEBIO INC IMA · 13G · filed 2026-05-14 IMA 8.5%≈ $5.7m +1.1 pts 13G 2026-05-14
ARBOR REALTY TRUST, INCORPORATED ABR 6.25 PERP E · 13G · filed 2025-02-14 ABR 6.25 PERP E 6.3% new 13G 2025-02-14
AKTIS ONCOLOGY INC AKTS · 13G · filed 2026-05-14 AKTS 5.9%≈ $101.9m new 13G 2026-05-14
BIOMEA FUSION INC BMEA · 13G · filed 2026-02-12 BMEA 5.9%≈ $6.5m +2.5 pts 13G 2026-02-12